In a medical breakthrough, first phase-3 dengue vaccine trial begins in India – The Economic Times

In a medical breakthrough, first phase-3 dengue vaccine trial begins in India  The Economic TimesICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll  MintPhase three clinical trial of India’s own dengue vaccine, DengiAll, initiated  The Times of IndiaIndia may soon get its 1st dengue vaccine, but jab effective against all 4 strains at least 3 yrs away  ThePrintDengue vaccine Phase 3 trials begin: Will this be an effective shield?  The Indian Express In a medical breakthrough, first phase-3 dengue vaccine trial begins in India  The Economic TimesICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll  MintPhase three clinical trial of India’s own dengue vaccine, DengiAll, initiated  The Times of IndiaIndia may soon get its 1st dengue vaccine, but jab effective against all 4 strains at least 3 yrs away  ThePrintDengue vaccine Phase 3 trials begin: Will this be an effective shield?  The Indian Express  Top stories – Google News